Table of Contents
1 Industry Overview of Deferiprone
1.1 Definition and Specifications of Deferiprone
1.1.1 Definition of Deferiprone
1.1.2 Specifications of Deferiprone
1.2 Classification of Deferiprone
1.3 Applications of Deferiprone
1.3.1 Nuclear Application
1.3.2 Non-Nuclear Application
1.4 Industry Chain Structure of Deferiprone
1.5 Industry Overview and Major Regions Status of Deferiprone
1.5.1 Industry Overview of Deferiprone
1.5.2 Global Major Regions Status of Deferiprone
1.6 Industry Policy Analysis of Deferiprone
1.7 Industry News Analysis of Deferiprone
2 Manufacturing Cost Structure Analysis of Deferiprone
2.1 Raw Material Suppliers and Price Analysis of Deferiprone
2.2 Equipment Suppliers and Price Analysis of Deferiprone
2.3 Labor Cost Analysis of Deferiprone
2.4 Other Costs Analysis of Deferiprone
2.5 Manufacturing Cost Structure Analysis of Deferiprone
2.6 Manufacturing Process Analysis of Deferiprone
3 Technical Data and Manufacturing Plants Analysis of Deferiprone
3.1 Capacity and Commercial Production Date of Global Deferiprone Major Manufacturers in 2023
3.2 Manufacturing Plants Distribution of Global Deferiprone Major Manufacturers in 2023
3.3 R&D Status and Technology Source of Global Deferiprone Major Manufacturers in 2023
3.4 Raw Materials Sources Analysis of Global Deferiprone Major Manufacturers in 2023
4 Capacity, Production and Revenue Analysis of Deferiprone by Regions, Types and Manufacturers
4.1 Global Capacity, Production and Revenue of Deferiprone by Regions 2019-2024
4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Deferiprone 2019-2024
4.3 Global Capacity, Production and Revenue of Deferiprone by Types 2019-2024
4.4 Global Capacity, Production and Revenue of Deferiprone by Manufacturers 2019-2024
5 Price, Cost, Gross and Gross Margin Analysis of Deferiprone by Regions, Types and Manufacturers
5.1 Price, Cost, Gross and Gross Margin Analysis of Deferiprone by Regions 2019-2024
5.2 Price, Cost, Gross and Gross Margin Analysis of Deferiprone by Types 2019-2024
5.3 Price, Cost, Gross and Gross Margin Analysis of Deferiprone by Manufacturers 2019-2024
6 Consumption Volume, Consumption Value and Sale Price Analysis of Deferiprone by Regions, Types and Applications
6.1 Global Consumption Volume and Consumption Value of Deferiprone by Regions 2019-2024
6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Deferiprone 2019-2024
6.3 Global Consumption Volume and Consumption Value of Deferiprone by Types 2019-2024
6.4 Global Consumption Volume and Consumption Value of Deferiprone by Applications 2019-2024
6.5 Sale Price of Deferiprone by Regions 2019-2024
6.6 Sale Price of Deferiprone by Types 2019-2024
6.7 Sale Price of Deferiprone by Applications 2019-2024
6.8 Market Share Analysis of Deferiprone by Different Sale Price Levels
7 Supply, Import, Export and Consumption Analysis of Deferiprone
7.1 Supply, Consumption and Gap of Deferiprone 2019-2024
7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2019-2024
7.3 USA Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2019-2024
7.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2019-2024
7.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2019-2024
7.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2019-2024
8 Major Manufacturers Analysis of Deferiprone
8.1 Manufacturer One
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Capacity, Production, Price, Cost, Gross and Revenue
8.1.4 Contact Information
8.2 Manufacturer Two
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Capacity, Production, Price, Cost, Gross and Revenue
8.2.4 Contact Information
8.3 Manufacturer Three
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Capacity, Production, Price, Cost, Gross and Revenue
8.3.4 Contact Information
8.4 Manufacturer Four
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Capacity, Production, Price, Cost, Gross and Revenue
8.4.4 Contact Information
8.5 Manufacturer Five
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Capacity, Production, Price, Cost, Gross and Revenue
8.5.4 Contact Information
…
9 Marketing Trader or Distributor Analysis of Deferiprone
9.1 Marketing Channels Status of Deferiprone
9.2 Traders or Distributors with Contact Information of Deferiprone by Regions
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Deferiprone
9.4 Regional Import, Export and Trade Analysis of Deferiprone
10 Industry Chain Analysis of Deferiprone
10.1 Upstream Major Raw Materials Suppliers Analysis of Deferiprone
10.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Deferiprone
10.1.2 Major Raw Materials Suppliers with Supply Volume Analysis of Deferiprone by Regions
10.2 Upstream Major Equipment Suppliers Analysis of Deferiprone
10.2.1 Major Equipment Suppliers with Contact Information Analysis of Deferiprone
10.2.2 Major Equipment Suppliers with Product Pictures Analysis of Deferiprone by Regions
10.3 Downstream Major Consumers Analysis of Deferiprone
10.3.1 Major Consumers with Contact Information Analysis of Deferiprone
10.3.2 Major Consumers with Consumption Volume Analysis of Deferiprone by Regions
10.4 Supply Chain Relationship Analysis of Deferiprone
11 Development Trend of Analysis of Deferiprone
11.1 Capacity, Production and Revenue Forecast of Deferiprone by Regions and Types
11.1.1 Global Capacity, Production and Revenue of Deferiprone by Regions 2024-2029
11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Deferiprone 2024-2029
11.1.3 Global Capacity, Production and Revenue of Deferiprone by Types 2024-2029
11.2 Consumption Volume and Consumption Value Forecast of Deferiprone by Regions, Types and Applications
11.2.1 Global Consumption Volume and Consumption Value of Deferiprone by Regions 2024-2029
11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Deferiprone 2024-2029
11.2.3 Global Consumption Volume and Consumption Value of Deferiprone by Types 2024-2029
11.2.4 Global Consumption Volume and Consumption Value of Deferiprone by Applications 2024-2029
11.3 Supply, Import, Export and Consumption Forecast of Deferiprone
11.3.1 Supply, Consumption and Gap of Deferiprone 2024-2029
11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2024-2029
11.3.3 USA Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2024-2029
11.3.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2024-2029
11.3.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2024-2029
11.3.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2024-2029
12 New Project Investment Feasibility Analysis of Deferiprone
12.1 New Project SWOT Analysis of Deferiprone
12.2 New Project Investment Feasibility Analysis of Deferiprone
13 Conclusion of the Global Deferiprone (CAS 30652-11-0) Industry 2024 Market Research Report
| ※参考情報 デフェリプロン（Deferiprone）は、主に体内の過剰な鉄を除去するための治療薬として使用される化合物です。CAS番号は30652-11-0で表され、特に鉄沈着症の患者に対して効果を示します。この薬剤は、遺伝性の血液疾患や慢性疾患に伴う鉄過剰が問題となる場合に用いられます。 デフェリプロンの特徴としては、その化学構造が挙げられます。これはリパミド誘導体であり、複数のヒドロキシル基を持ち、鉄イオンと強く結合する特性があります。これにより、デフェリプロンは体内の過剰な鉄と結合し、これを尿中に排泄させることが可能になります。このメカニズムにより、鉄過剰による各種合併症のリスクを軽減することができます。 デフェリプロンは、特にβ-サラセミアや鉄過剰症に伴う慢性疾患、さらには骨髄疾患に対して処方されることが多いです。これらの疾患はしばしば繰り返し輸血を必要とし、その結果として体内に蓄積された鉄の量が増加します。そのため、適切な治療措置が求められます。デフェリプロンは、主に成人および小児の患者に使用されることがあり、特に慢性の鉄過剰に苦しむ患者において効果的な治療法の一つとされています。 デフェリプロンの使用にはいくつかの利点が存在します。まず、他の鉄キレーター薬と比較して、体内の鉄を効果的に取り除くことができるという点が挙げられます。また、経口投与が可能であるため、患者の服薬のしやすさも考慮されています。加えて、デフェリプロンの治療により、心臓や肝臓などの主要臓器への鉄の蓄積を防ぎ、組織障害を回避することが期待されます。 一方で、デフェリプロンには副作用も存在します。最も一般的な副作用としては、白血球数の減少（好中球減少症）や関節痛、下痢などが報告されています。これにより、定期的な血液検査が必要となり、患者の健康状態を注意深くモニタリングすることが求められます。また、過敏症やアレルギー反応も稀に発生することがあり、そのため医療従事者との緊密な連携が重要です。 デフェリプロンは、他の鉄除去薬と組み合わせて使用されることもあります。特に体内の鉄除去が難しい場合、デフェリプロンと他の薬剤との併用が効果的であるとされ、個別の患者の状態に応じた最適な治療計画を立てることが重要です。 新しい関連技術としては、非侵襲的な鉄測定技術の開発が挙げられます。これにより、患者の体内における鉄の蓄積状況を正確に把握することが可能となり、デフェリプロンの効果を最大限に引き出すための個別化医療が進展することが期待されます。また、薬剤の改良が進められており、より効果的かつ副作用の少ない新しい鉄キレーターの開発が進行中です。 総じて、デフェリプロンは鉄過剰症の治療において重要な役割を果たしており、その特性や使用方法、副作用について理解を深めることが、患者の治療にとって不可欠です。今後もさらなる研究と技術革新により、デフェリプロンとその治療効果が向上し、より多くの患者に恩恵をもたらすことが期待されます。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
